XML 193 R68.htm IDEA: XBRL DOCUMENT v3.24.4
Commitments and Contingencies (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 19, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
May 30, 2023
USD ($)
Jan. 31, 2021
USD ($)
Nov. 30, 2020
USD ($)
Jan. 01, 2016
USD ($)
Jan. 01, 2016
EUR (€)
Mar. 31, 2015
USD ($)
Mar. 31, 2015
USD ($)
Mar. 31, 2015
EUR (€)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Commitments and Contingencies [Line Items]                              
Cumulative total payments           $ 2,142,920 € 2,000,000   $ 16,013,000 € 15,000,000          
Net sales revenue percentage           1.00% 1.00%   3.00% 3.00%          
Sublicensing revenue           2.00% 2.00%   10.00% 10.00%          
Milestone payment percentage         10.00% 2.00% 2.00%   25.00% 25.00%          
Royalty payment                 1.00% 1.00%          
Revenue received                 $ 100,000,000            
Issuance of a promissory note               $ 1,400,000              
Payment of other asset         $ 50,000                    
Royalty, percentage         1.50%                    
Commercial sales         $ 2,000,000                    
Received of upfront payments         $ 2,000,000                    
License agreement terms         11 years                    
Payable amount         $ 2,000,000                    
Payment of note payable       $ 50,000                      
Consulting fee $ 320,000                            
Issuance of value                     $ (186,050) $ (405,753) $ (394,736) $ (1,055,985)  
Issuance of promissory note   $ 1,211,463           $ 1,400,000 1,400,000     $ 1,211,463   $ 1,211,463 $ 1,211,463
Rent expense                             $ 8,000
Previously Reported [Member]                              
Commitments and Contingencies [Line Items]                              
Cumulative total payments           $ 2,135,000                  
Spartan Consulting Agreement [Member]                              
Commitments and Contingencies [Line Items]                              
Consulting fee   160,000 $ 480,000                        
Consulting Agreement [Member]                              
Commitments and Contingencies [Line Items]                              
Consulting fee   $ 160,000 $ 480,000                        
Issuance of shares (in Shares) | shares 582,331                            
Maximum [Member]                              
Commitments and Contingencies [Line Items]                              
Cumulative total payments           3,348,060 € 3,000,000                
Maximum [Member] | Previously Reported [Member]                              
Commitments and Contingencies [Line Items]                              
Cumulative total payments           $ 3,203,000     8,540,000            
Minimum [Member]                              
Commitments and Contingencies [Line Items]                              
Cumulative total payments                 8,928,160 € 8,000,000          
Common Shares [Member] | Spartan Consulting Agreement [Member]                              
Commitments and Contingencies [Line Items]                              
Issuance of shares (in Shares) | shares 582,331                            
Issuance of value $ 3,202,823                            
Common Shares [Member] | Consulting Agreement [Member]                              
Commitments and Contingencies [Line Items]                              
Issuance of shares (in Shares) | shares 14,558,285                            
Galantos Pharma GmbH [Member]                              
Commitments and Contingencies [Line Items]                              
Cumulative total payments                 11,160,200 10,000,000          
Galantos Pharma GmbH [Member] | Previously Reported [Member]                              
Commitments and Contingencies [Line Items]                              
Cumulative total payments                 10,675,000            
Galantos Pharma GmbH [Member] | Maximum [Member]                              
Commitments and Contingencies [Line Items]                              
Cumulative total payments                 $ 16,740,300            
Galantos Pharma GmbH [Member] | Minimum [Member]                              
Commitments and Contingencies [Line Items]                              
Cumulative total payments | €                   € 15,000,000